HCPCS J1303
Inj., ravulizumab-cwvz 10 mg
HCPCS J1303 at a glance
- Code
- J1303
- Code type
- CPT/HCPCS
- Short descriptor
- Inj., ravulizumab-cwvz 10 mg
- Category
- ASC Ancillary
- ASC payment status
- Payable in an ASC (ancillary)
- CMS addendum
- BB (Ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is HCPCS code J1303?
HCPCS J1303 is a CPT/HCPCS procedure code. Its official CMS short descriptor is "Inj., ravulizumab-cwvz 10 mg". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS J1303 payable in an ambulatory surgery center (ASC)?
HCPCS J1303 is a covered ancillary service (CMS Addendum BB). Medicare reimburses it in the ASC setting when it is integral to a covered ASC surgical procedure.
Where is HCPCS J1303 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
Reference information compiled from the CMS April 2026 ASC payment addenda (AA, BB, EE). Codes, descriptors, and ASC payment status change with each CMS update. This is a coding reference, not billing, coding, or legal advice. Always verify against the current CMS addenda and individual payer policy before billing. CPT is a registered trademark of the American Medical Association.